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Abstract: 3-Nitroacetophenone (3-NAP) is an organic compound used as an intermediate for the synthesis of pharmaceutical 
agents. The aim of this study was to evaluate the impact of biofield energy treatment on the physical, thermal and spectral 
properties of 3-NAP. The study was performed in two groups i.e. control and treated. The control group remained as untreated, 
and the treated group received Mr. Trivedi’s biofield energy treatment. The control and treated 3-NAP samples were further 
characterized by X-ray diffraction (XRD), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), laser 
particle size analyzer, surface area analyzer, Fourier transform infrared (FT-IR) spectroscopy, and ultra violet-visible 
spectroscopy (UV-vis) analysis. The XRD analysis showed decrease in crystallite size of treated 3-NAP by 20.27% as 
compared to the control sample. However, the XRD peaks of treated sample showed an increase in intensity as compared to the 
control. The DSC result showed a slight increase in melting temperature of treated 3-NAP (80.75ºC) with respect to the control 
(79.39ºC). The latent heat of fusion of treated 3-NAP was changed by 16.28% as compared to the control sample. The TGA 
analysis showed an increase in onset temperature of treated sample (192ºC) as compared to the control sample (182ºC). 
Further, the maximum thermal decomposition temperature (Tmax) of treated 3-NAP was increased as compared to the control. 
This showed the increase in thermal stability of treated 3-NAP with respect to control. The treated 3-NAP showed an increase 
in average particle size (d50) by 27.6% along with an increase in size exhibited by 99% of particles (d99) by 4.9% as compared 
to the control. Brunauer-Emmett-Teller (BET) analysis showed a substantial decrease in surface area by 24.6% with respect to 
the control. The FT-IR analysis showed an emergence of peak at 1558 cm-1 in treated 3-NAP sample as compared to the 
control. Nevertheless, the UV spectral analysis of treated 3-NAP showed no alterations in absorption peaks as compared to the 
control. Altogether, the result showed that biofield energy treatment has altered the physical, thermal and spectral properties of 
treated 3-NAP as compared to the control. 
Keywords: X-Ray Diffraction, Thermal Analysis, Laser Particle Size Analysis, Surface Area Analysis, Fourier Transform 
Infrared Spectroscopy, Ultra Violet-Visible Spectroscopy 
 
1. Introduction 
Nitroaromatic compounds are one of the important group 
of industrial chemicals in use today. These organic 
compounds consist of at least one –NO2 group which is 
attached to the aromatic ring [1]. Many pharmaceuticals are 
originated from nitroaromatic compounds. For instance, 
many substituted nitroaromatic compounds are used to 
synthesize the diverse collection of indoles that are bioactive 
components of many drugs and agrochemicals [2]. 
Nitroacetophenone are nitroaromatic compounds that have 
been commonly used in the synthesis of chemical and 
pharmaceutical compounds. 4-Nitroacetophenone based 
compounds are recently recognized as a class of anti-
trypanosomal drug candidates [3]. 2-Nitroacetophenone is 
used as an intermediate for the synthesis of cinoxacin that is 
prescribed for urinary tract infections in adults [4]. 3-
Nitroacetophenone (3-NAP) is a compound used as 
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intermediate for the synthesis of flurbiprofen that is 
administered for the treatment of inflammation and arthritis 
pain [5]. Iradyan et al. synthesized 3-NAP derivatives and 
investigated its antitumor efficiency [6]. Chalcones are an 
important class of compounds associated with excellent 
pharmacological activity [7]. Chalcones are synthesized from 
3-NAP as an intermediate compound, which have profound 
anti-inflammatory [8], anti-ulcerative [9], antibacterial [10], 
antifungal [11] and antimalarial activities [12]. 
Pharmaceutical stability is a key factor that determines the 
therapeutic efficacy and toxicity of medications. According 
to Food and Drug Administration (FDA), the drug companies 
should determine a time limit to which they can assure the 
full potency and safety of the medications [13]. Therefore, 
chemical and physical stability of the pharmaceutical 
compounds are more desired quality attributes that directly 
affect its safety, efficacy, and shelf life [14]. Thus, exploring 
new methods that can improve the physicochemical 
properties of active pharmaceutical ingredients will be like 
the gold standard in the pharmaceutical development. 
Recently biofield energy treatment was utilized as novel 
method for changing the physical and thermal properties of 
various materials such as metals [15, 16], ceramics [17], 
organic product [18] and spectral properties of various 
pharmaceutical drugs [19]. Therefore author planned to study 
the influence of biofield energy treatment on the physical, 
thermal and spectral properties of 3-NAP.  
In United States the National Centre for Complementary 
and Alternative Medicine (NCCAM), which is a part of the 
prestigious National Institute of Health (NIH), authorizes the 
use of Complementary and Alternative Medicine (CAM) 
therapies as an alternative in the healthcare sector. According 
to an estimate about 36% of Americans regularly uses some 
form of CAM [20], in their day-to-day activities. CAM 
embraces numerous energy-healing therapies; biofield 
therapy is one of the energy medicine used worldwide to 
alleviate overall human health.  
Biofield energy treatment consists of practices based on 
subtle energy field and generally reflect the concept that 
human being are infused with this form of energy [21]. 
Researchers have shown that a unique bioenergetic field 
surrounds and permeates the human body [22]. This 
bioenergetic field regulates the human health and during 
disease condition this unique field is depleted [23]. Recently 
some medical technologies were used to measure this human 
biofield [24]. 
Therefore, it is envisaged that human beings have the 
ability to harness the energy from the environment/Universe 
and can transmit into any object (living or non-living) around 
the Globe. The object(s) will always receive the energy and 
responding in a useful manner that is called biofield energy. 
Mr. Trivedi is known to transform the characteristics of 
various living and non-living things using his unique biofield 
energy. This biofield energy treatment is also known as The 
Trivedi Effect®. It is known to change the phenotype 
characteristics of microbes [25, 26] and improved the growth 
and anatomical characteristics of medicinal plants [27, 28]. 
Due to pharmaceutical significance of 3-NAP as an 
intermediate and literature reports on biofield energy 
treatment as a useful approach, the present work was 
undertaken to evaluate the impact of this treatment on 
physical, thermal and spectral properties of 3-NAP. 
2. Materials and Methods 
3-Nitroacetophenone (3-NAP) was procured from S D 
Fine Chemicals Limited, India. The sample was divided into 
two parts; one was kept as the control sample while the other 
was subjected to Mr. Trivedi’s unique biofield energy 
treatment and coded as treated sample. The treated sample 
was in sealed pack and handed over to Mr. Trivedi for 
biofield energy treatment under laboratory condition. Mr. 
Trivedi gave the energy treatment through his unique energy 
transmission process to the treated samples without touching 
it. The control and treated samples were further characterized 
by various analytical techniques such as X-ray diffraction, 
differential scanning calorimetry, thermogravimetric analysis, 
laser particle size analyzer, surface area analyzer, Fourier 
transform infrared spectroscopy, and ultra violet-visible 
spectroscopy analysis. 
2.1. X-ray Diffraction (XRD) Study 
XRD analysis of control and treated 3-NAP was evaluated 
using X-ray diffractometer system, Phillips, Holland PW 
1710 which consist of a copper anode with nickel filter. XRD 
system had a radiation of wavelength 1.54056 Å. The 
average crystallite size (G) was computed using formula: 
G = kλ/(bCosθ) 
Here, λ is the wavelength of radiation used, b is full width 
half-maximum (FWHM) of peaks and k is the equipment 
constant (=0.94). Percentage change in average crystallite 
size was calculated using following formula: 
Percentage change in crystallite size = [(Gt-Gc)/Gc] ×100  
Where, Gc and Gt are denoted as crystallite size of control 
and treated powder samples respectively. 
2.2. Differential Scanning Calorimetry (DSC) 
The control and treated 3-NAP samples were analyzed 
using Pyris-6 Perkin Elmer DSC at a heating rate of 
10ºC/min under air atmosphere and the air was flushed at a 
flow rate of 5 mL/min. The predetermined amount of sample 
was kept in an aluminum pan and closed with a lid. A blank 
aluminum pan was used as a reference. The percentage 
change in latent heat of fusion was calculated using 
following equations: 
% change in Latent heat of fusion  
=
H  − ΔH  
ΔH 
× 100  
Where, ∆H Control and ∆H Treated are represented as the latent 
heat of fusion of control and treated samples, respectively. 
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2.3. Thermogravimetric Analysis-Differential Thermal 
Analysis (TGA-DTA) 
A Mettler Toledo simultaneous TGA and Differential 
thermal analyzer (DTA) was used to investigate the thermal 
stability of control and treated 3-NAP samples. The heating 
rate was 5ºC/min and the samples were heated in the range of 
room temperature to 400ºC under air atmosphere. 
2.4. Particle Size Analysis 
A Sympetac Helos-BF laser particle size analyzer was 
used to evaluate the particle size distribution of 3-NAP 
samples using a measurement range of 0.1 to 875 µm. The 
average particle size d50 and d99 size showed by 99% of 
powder particles were calculated. The percentage changes in 
d50 and d99 values were computed using following formula: 
Percentage change in d50 size = 100 × (d50 treated - d50 
control)/ d50 control 
Percentage change in d99 size = 100 × (d99 treated - d99 
control)/ d99 control 
2.5. Surface Area Analysis 
A SMART SORB 90 Brunauer-Emmett-Teller (BET) 
surface area analyzer with a detection range of 0.2-1000 m2/g 
was used to evaluate the surface area of 3-NAP samples. The 
samples were analyzed using a standard ASTM D 5604 
method. The Percent changes in surface area were computed 
using following formula: 
% change in surface area 
S   S  
S 
! 100 
Where, S Control and S Treated are the surface area of control 
and treated samples respectively. 
2.6. FT-IR Spectroscopy 
The FT-IR spectra were recorded on Shimadzu’s Fourier 
transform infrared spectrometer (Japan) with the frequency 
range of 4000-500 cm-1. The analysis was accomplished to 
evaluate the effect of biofield treatment at the atomic level 
like dipole moment, force constant and bond strength in 
chemical structure [29]. The treated sample was divided into 
two parts T1 and T2 for FT-IR analysis. 
2.7. UV-Vis Spectroscopic Analysis 
A Shimadzu UV-2400 PC series spectrophotometer with 1 
cm quartz cell and a slit width of 2.0 nm was used to obtain 
the UV spectra of the control and treated 3-NAP samples. 
The spectroscopic analysis was carried out using wavelength 
in the range of 200-400 nm and methanol was used as a 
solvent. The UV spectra were analyzed to determine the 
effect of biofield treatment on the energy gap of highest 
occupied molecular orbital (HOMO) and lowest unoccupied 
molecular orbital (LUMO) [29]. The treated sample was 
divided in two parts T1 and T2 for the UV-Vis spectroscopic 
analysis. 
 
Fig. 1. XRD diffractograms of control and treated 3-nitroacetophenone. 
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3. Results and Discussion 
3.1. XRD Study 
XRD studies were used to investigate the crystalline 
nature of the control and treated samples. Fig. 1 shows the 
XRD diffractograms of control and treated 3-NAP samples. 
XRD diffractogram of control 3-NAP showed intense 
crystalline peaks at 12.19º, 15.77º, 16.57º, 19.73º, 23.90º, 
24.50º, 25.98º, 27.14º, 27.42º, and 37.10º. However, the 
treated sample showed intense crystalline peaks at 12.20º, 
15.68º, 15.78º, 16.57º, 19.73º, 23.96º, 24.50º, 25.97º, 
27.16º, 27.46º, and 37.08º. The intensity of XRD peaks at 
Bragg’s (2θ) angle 12.20º, 15.68º, 19.73º, and 27.16º in 
treated samples were increased as compared to the control 
sample. This showed the probable increase in crystallinity 
of the treated 3-NAP as compared to the control sample. 
Inoue et al. showed that an alteration in crystal morphology 
might cause the changes in intensity of the XRD peaks [30]. 
Hence, it is assumed that biofield treatment might cause 
changes in crystal morphology of the treated 3-NAP that 
may lead to increase in the intensity of the XRD peaks as 
compared to the control. 
The crystallite size an important crystallographic factor 
was computed using the Scherrer formula and the results are 
depicted in Fig. 2. The crystallite size of control 3-NAP was 
81.45 nm while it was decreased to 64.94 nm in the treated 
sample. The result showed 20.27% decrease in crystallite size 
of the treated sample as compared to the control sample. It 
was reported that presence of internal strain and increase in 
atomic displacements from their ideal lattice positions causes 
a reduction in crystallite size [31]. Crystallite size reduction 
is perhaps the most distinguished feature of 
mechanochemical treatment. Many researchers have shown 
that average crystallite size of ceramics or metal powders 
decreases rapidly during milling [32-35]. Dittrich et al. 
showed that mechanical milling method caused a substantial 
decrease in crystallite size [36]. Hence, it is assumed that 
biofield treatment may provide the energy that caused an 
increase in strain and displacement in ideal lattice positions 
of treated 3-NAP sample that caused a decrease in the 
crystallite size. 
 
Fig. 2. Crystallite size of control and treated 3-nitroacetophenone. 
3.2. DSC Study 
DSC thermograms of control and treated 3- NAP are 
presented in Fig. 3. DSC thermogram of control 3-NAP 
showed an intense endothermic peak at 79.39ºC that was due 
to melting temperature of the sample. However, the treated 3-
NAP showed an endothermic peak at 80.75ºC due to melting 
temperature of the treated sample. This suggests the slight 
increase in melting temperature of treated sample as 
compared to the control. It is assumed that intermolecular 
interaction forces are more pronounced in treated 3-NAP that 
leads to increase in the packing of the molecules and increase 
in melting temperature. 
The latent heat of fusion of control and treated 3-NAP 
samples were obtained from the DSC thermogram and data 
are presented in Table 1. The latent heat of fusion of control 
3-NAP was 119.72 J/g, and it was decreased to 100.23 J/g in 
the treated sample. The results suggested the 16.28% 
decrease in the latent heat of fusion of the treated 3-NAP as 
compared to the control sample. Latent heat of fusion is the 
energy absorbed in a material during its phase change from 
solid to liquid. It is assumed here that biofield energy 
treatment might cause alteration in the internal energy that 
might lead to change in latent heat of fusion of the treated 
sample. 
 
Fig. 3. DSC thermograms of control and treated 3-nitroacetophenone. 
3.3. TGA Study 
Thermogravimetric analysis was used to investigate the 
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thermal stability of the control and treated 3-NAP. The TGA 
thermogram of control and treated samples are presented in 
Fig. 4. TGA thermogram of control 3-NAP showed onset 
temperature at around 182ºC and end set temperature at 
around 229ºC. During this thermal process, the sample lost 
53.67% of its initial weight. However, the treated 3-NAP 
showed onset temperature at around 192ºC and the end set 
temperature was found at 223ºC. The treated 3-NAP lost 
around 46.94% weight during this process. The result showed 
the increase in onset temperature of thermal decomposition 
of treated sample as compared to the control. This indicated 
the increase in thermal stability of the treated sample as 
compared to the control. 
The DTA thermogram of control and treated 3-NAP are 
depicted in Fig. 4. DTA thermogram of control 3-NAP 
showed two endothermic transitions in the sample. The 
former peak at 79.03ºC was due to melting temperature of the 
sample and later peak at 209.94ºC was due to thermal 
decomposition of the sample. Similarly, the treated sample 
showed endothermic peaks at 78.81ºC and 211.93ºC. This 
showed an increase in thermal decomposition temperature of 
the treated 3-NAP as compared to the control. 
The DTG thermogram of control and treated 3-NAP 
samples are presented in Fig. 4. DTG thermogram of control 
sample showed maximum thermal decomposition 
temperature (Tmax) at 200.80ºC and it was increased up to 
206.93ºC in the treated 3-NAP. Overall, the increase in onset 
temperature, Tmax and reduction in weight loss of treated 
sample indicated an increase in thermal stability of treated 3-
NAP as compared to the control. DTA analysis also 
supported the above observation. 
 
Fig. 4. TGA thermograms of control and treated 3-nitroacetophenone. 
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Table 1. Thermal analysis data of control and treated 3-nitroacetophenone. 
Parameter Control Treated 
Latent heat of fusion ∆H (J/g) 119.72 100.23 
Melting temperature (ºC) 79.39 80.75 
Tmax (ºC) 200.80 206.93 
Weight loss (%) 53.67 46.94 
3.4. Particle Size and Surface Area Analysis 
The particle size of the control and treated 3-NAP samples 
were analyzed by laser particle size analyzer, and the data are 
presented in Fig. 5. The average particle size (d50) and size 
exhibited by 99% of the particles (d99) were obtained from 
the particle size distribution curve. The average particle size 
of the control 3-NAP was 204.39 µm and increased to 260.81 
µm in the treated sample. Whereas the d99 of the control 3-
NAP was 658.17 µm and increase up to 690.20 µm in the 
treated sample. The results suggested the 27.6 and 4.9 % 
increase in d50 and d99, respectively of the treated sample as 
compared to the control. Vinila et al. showed that particle 
size of a ceramic material increases with elevation in 
temperature [37]. Additionally, Iqbal et al. suggested that due 
to annealing the particles collide and coalesce with one 
another to form a bigger particle [38]. Hence, it is assumed 
here that biofield treatment may provide the energy that 
causes a collision, and coalescence in the treated 3-NAP 
particles leading to the formation of bigger particles. 
 
Fig. 5. Particle size (d50 and d99) of control and treated 3-nitroacetophenone. 
 
Fig 6. FT-IR spectra of control and treated 3-nitroacetophenone (T1 and T2). 
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BET was used to investigate the surface area of control 
and treated 3-NAP samples. The surface area of the control 
sample was 0.5910 m2/g, and it was decrease to 0.4455 m2/g 
in the treated sample. The result suggested the 24.6% 
decrease in surface area of the treated 3-NAP as compared to 
the control. The particle size is inversely proportional to 
surface area. Hence, an increase in particle size decreases the 
surface area and vice versa. Therefore, the increase in d50 and 
d99 probably caused a resultant decrease in the surface area of 
the treated sample. 
3.5. FT-IR Spectroscopy 
FT-IR spectroscopy was used to investigate the spectral 
changes in the sample after biofield treatment. FT-IR spectra 
of control and treated 3-NAP are presented in Fig. 6. The FT-
IR spectrum of control, T1, and T2 samples showed methyl (-
CH3) stretching vibration peaks at 3090 and 3105 cm
-1 
respectively. The characteristic carbonyl (C=O) group 
stretching was noticed at 1691 cm-1 in control sample while 
in T1 and T2 it appeared at 1689 cm-1. The FT-IR spectrum 
of control 3-NAP, T1 and T2 showed absorptions peaks in 
the region of 1317-1350 cm-1 that was due to the symmetric 
vibration of the NO2 group. The C=C (aromatic) stretching 
peaks were observed at 1471, 1525, and 1577 cm-1 in the 
control sample, while T1 sample showed at 1471, 1525, and 
1577 cm-1. Whereas, the T2 sample showed C=C stretching 
at 1471, 1525, 1558, and 1577 cm-1. The C-C stretching was 
observed at 1431 cm-1 in control, T1, and T2 samples. The 
vibration peaks in the region of 1251-1278 cm-1 were due C-
N stretching mode in the control and T1 samples. Whereas 
the T2 sample showed C-N stretching peak at 1249-1276 cm-
1. The C-H in plane bending was noticed at 1111 cm-1in the 
control sample while the T1 and T2 sample showed in the 
region of 1111-1170 cm-1. The C-H out of plane bending 
peaks in the control sample was in the region of 663-675 cm-
1. However, the T1 and T2 sample showed C-H out of plane 
bending peaks at 663, 673 cm-1 and 663 cm-1. Overall, the 
FT-IR results showed an emergence of new peak at 1558 cm-
1 in the treated 3-NAP (T2) sample as compared to control. It 
is assumed that biofield treatment might induce some 
alteration in C=C (aromatic) stretching peak of the treated 
sample (T2) that lead to emergence of this new peak.  
3.6. UV-vis Spectroscopy 
UV-vis spectra of control and treated 3-NAP are presented 
in Fig. 7. The UV spectra of control 3-NAP showed an 
absorption peak at 225 nm. Similarly, the treated 3-NAP 
samples (T1 and T2) showed absorption peak at 225 nm. 
Hence, the result showed no change in absorption peak of 
treated sample as compared to the control sample. Therefore, 
it is suggested that the biofield treatment did not disturb the 
energy gap between HOMO-LUMO [29] in treated sample, 
and it was found similar to the control sample.  
 
Fig. 7. UV spectra of control and treated 3-nitroacetophenone (T1 and T2). 
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4. Conclusions 
In summary, XRD data revealed the decrease in 
crystallite size of treated sample by 20.27% and an increase 
in the intensity of peaks as compared to the control sample. 
It is assumed that biofield treatment may provide the energy 
that caused an increase in strain and displacement of ideal 
lattice positions leading to decrease in crystallite size. DSC 
analysis showed a change in the latent heat of fusion of 
treated 3-NAP by 16.28% with respect to the control 
sample. TGA analysis revealed the increase in thermal 
stability of treated 3-NAP, which was evidenced by an 
increase in Tmax and onset temperature of the treated 
sample. Additionally, reduction in weight loss of treated 3-
NAP was noticed as compared to the control. Particle size 
analysis showed an increase in d50 and d99 by 27.6 and 
4.9%, respectively as compared to the control sample. It is 
assumed that biofield treatment provided the energy that 
caused treated 3-NAP particles to coalesce with one another 
to form bigger microparticles. BET analysis showed a 
substantial decrease in surface area of treated sample that 
was supported by an increase in particle size. FT-IR 
analysis showed an emergence of new peak at 1558 cm-1 
after biofield treatment in 3-NAP as compared to the 
control sample. Overall, the result demonstrated that 
biofield energy treatment has affected the physical, thermal 
and spectral properties of treated 3-NAP. It is assumed that 
biofield treated 3-NAP could be used as intermediate for 
synthesis of pharmaceutical compounds. 
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